4:26 PM
 | 
Sep 12, 2017
 |  BC Extra  |  Company News

Gene therapy company Rocket finds public path

Ophthalmic play Inotek Pharmaceuticals Corp. (NASDAQ:ITEK) will merge with gene therapy company Rocket Pharmaceuticals Ltd. (New York, N.Y.). The combined company will retain Rocket's name and will be located in New York. The partners expect the deal to close in 1Q18.

Rocket shareholders will own about 81% of the combined...

Read the full 232 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >